"Drugmaker Merck & Co. is suspending its sale of the cholesterol drug Tredaptive after initial results from a study showed that it wasn't effective and could raise the risk of some serious side effects."Are we supposed to believe that Merck just found that out? Why did the stock rise? Insiders must have known this was coming and built it into the price.
It looks like the alarmism about the flu and the government's inability to deal with it have had the desired result: more flu vaccines being used.
No comments:
Post a Comment